Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.sandu.in | |
Market Cap | 66.71 Cr. | |
Enterprise Value(EV) | 60.53 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 1.46 | Trailing Twelve Months Ending 2023-09 |
Price-Earning Ratio (PE) | 47.18 | Trailing Twelve Months Ending 2023-09 |
Industry PE | 38.52 | Trailing Twelve Months Ending 2023-09 |
Book Value / Share | 32.52 | Trailing Twelve Months Ending 2023-09 |
Price to Book Value | 2.12 | Calculated using Price: 69.05 |
Dividend Yield | 1.09 | Period Ending 2023-03 |
No. of Shares Subscribed | 0.97 Cr. | 9,660,990 Shares |
FaceValue | 10 | |
About Sandu Pharmaceuticals Ltd. | ||
Sandu Pharmaceuticals incorporated in 1985, is engaged in manufacturing of ayurvedic medicines. The company operates a distribution network in India as well as in the overseas markets. |
1 Day |
|
+2.98% |
1 Week |
|
+1.77% |
1 Month |
|
+2.71% |
3 Month |
|
+12.13% |
6 Month |
|
+19.26% |
1 Year |
|
+8.65% |
2 Year |
|
+51.93% |
5 Year |
|
+168.68% |
10 Year |
|
+590.50% |
1 years | 2023-03 | |
Return on Equity (%) | 5.00 | |
Return on Capital Employed (%) | 7.55 | |
Return on Assets (%) | 2.81 |
Particulars | 2 years | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 39 | 40 | |
Non Curr. Liab. | 1 | 1 | |
Curr. Liab. | 14 | 12 | |
Minority Int. | |||
Equity & Liab. | 54 | 53 | |
Non Curr. Assets | 29 | 28 | |
Curr. Assets | 26 | 25 | |
Misc. Exp. not W/O | |||
Total Assets | 54 | 53 |
Particulars | 2 years | 2023-03 Rs. Cr. | 2023-09 Rs. Cr. TTM |
Net Sales | 65 | 67 | |
Other Income | 0 | 0 | |
Total Income | 66 | 67 | |
Total Expenditure | -63 | -64 | |
PBIDT | 3 | 3 | |
Interest | 0 | 0 | |
Depreciation | -1 | -1 | |
Taxation | -1 | -1 | |
Exceptional Items | |||
PAT | 2 | 1 | |
Minority Interest | |||
Share Associate | |||
Other Related Items | |||
Consolidated Net Profit | 2 | 1 | |
Adjusted EPS | 2 | 1 |
Particulars | 1 years | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | |
Cash Fr. Inv. | 1 | |
Cash Fr. Finan. | 1 | |
Net Change | 1 | |
Cash & Cash Eqvt | 2 |
Wed, 22 Nov 2023
Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO) Resignation of Shri Rakesh Parekh as Chief Financial Officer of the Company |
Wed, 22 Nov 2023
Announcement under Regulation 30 (LODR)-Change in Management Resignation of Shri Rakesh parekh as Chief Financial Officer of the Company |
Sat, 18 Nov 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate stop transfer for duplicate issue of share certificate- pravin oswal |
Fri, 08 Dec 2023 |
|
|
|
|
|